News and Trends 30 Nov 2022
AstraZeneca splashes out up to $320M on T-cell receptor therapy company
Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts),…